(5Z,13E)-(15S)-9α,11α,15-trihydroxyprosta-5,13-dienoate:NADP+ 11-oxidoreductase inhibitor
|
ChEBI
|
(5Z,13E)-(15S)-9α,11α,15-trihydroxyprosta-5,13-dienoate:NADP+ 11-oxidoreductase inhibitors
|
ChEBI
|
EC 1.1.1.188 (prostaglandin-F synthase) inhibitors
|
ChEBI
|
EC 1.1.1.188 inhibitor
|
ChEBI
|
EC 1.1.1.188 inhibitors
|
ChEBI
|
NADPH-dependent prostaglandin D2 11-keto reductase inhibitor
|
ChEBI
|
NADPH-dependent prostaglandin D2 11-keto reductase inhibitors
|
ChEBI
|
PGD2 11-ketoreductase inhibitor
|
ChEBI
|
PGD2 11-ketoreductase inhibitors
|
ChEBI
|
PGF synthetase inhibitor
|
ChEBI
|
PGF synthetase inhibitors
|
ChEBI
|
PGF2α synthetase inhibitor
|
ChEBI
|
PGF2α synthetase inhibitors
|
ChEBI
|
prostaglandin 11-keto reductase inhibitor
|
ChEBI
|
prostaglandin 11-keto reductase inhibitors
|
ChEBI
|
prostaglandin 11-ketoreductase inhibitor
|
ChEBI
|
prostaglandin 11-ketoreductase inhibitors
|
ChEBI
|
prostaglandin D2-ketoreductase inhibitor
|
ChEBI
|
prostaglandin D2-ketoreductase inhibitors
|
ChEBI
|
prostaglandin F synthase inhibitor
|
ChEBI
|
prostaglandin F synthase inhibitors
|
ChEBI
|
prostaglandin F synthetase inhibitor
|
ChEBI
|
prostaglandin F synthetase inhibitors
|
ChEBI
|
prostaglandin-D2 11-reductase inhibitor
|
ChEBI
|
prostaglandin-D2 11-reductase inhibitors
|
ChEBI
|
reductase, 15-hydroxy-11-oxoprostaglandin inhibitor
|
ChEBI
|
reductase, 15-hydroxy-11-oxoprostaglandin inhibitors
|
ChEBI
|
synthetase, prostaglandin F2α inhibitor
|
ChEBI
|
synthetase, prostaglandin F2α inhibitors
|
ChEBI
|